During the last session, ClearPoint Neuro Inc (NASDAQ:CLPT)’s traded shares were 0.35 million, with the beta value of the company hitting 0.95. At the end of the trading day, the stock’s price was $11.97, reflecting an intraday loss of -3.62% or -$0.45. The 52-week high for the CLPT share is $19.22, that puts it down -60.57 from that peak though still a striking 57.31% gain since the share price plummeted to a 52-week low of $5.11. The company’s market capitalization is $330.76M, and the average intraday trading volume over the past 10 days was 0.19 million shares, and the average trade volume was 233.38K shares over the past three months.
ClearPoint Neuro Inc (NASDAQ:CLPT) trade information
ClearPoint Neuro Inc (CLPT) registered a -3.62% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.62% in intraday trading to $11.97, hitting a weekly high. The stock’s 5-day price performance is -10.54%, and it has moved by -15.73% in 30 days. Based on these gigs, the overall price performance for the year is 83.03%. The short interest in ClearPoint Neuro Inc (NASDAQ:CLPT) is 0.74 million shares and it means that shorts have 2.48 day(s) to cover.
The consensus price target of analysts on Wall Street is $30, which implies an increase of 60.1% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $30 and $30 respectively. As a result, CLPT is trading at a discount of -150.63% off the target high and -150.63% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -10.69%. While earnings are projected to return 9.30% in 2025, the next five years will return 3.45% per annum.
CLPT Dividends
ClearPoint Neuro Inc is due to release its next quarterly earnings on 2025-Feb-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ClearPoint Neuro Inc (NASDAQ:CLPT)’s Major holders
ClearPoint Neuro Inc insiders own 8.01% of total outstanding shares while institutional holders control 33.26%, with the float percentage being 36.16%. VANGUARD GROUP INC is the largest shareholder of the company, while 110.0 institutions own stock in it. As of 2024-06-30, the company held over 1.22 million shares (or 4.779% of all shares), a total value of $6.56 million in shares.
The next largest institutional holding, with 0.47 million shares, is of MILLENNIUM MANAGEMENT LLC’s that is approximately 1.6946% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $2.51 million.
Also, the Mutual Funds coming in first place with the largest holdings of ClearPoint Neuro Inc (CLPT) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 804.25 shares. This amounts to just over 2.91 percent of the company’s overall shares, with a $9.63 million market value. The same data shows that the other fund manager holds slightly less at 404.83, or about 1.47% of the stock, which is worth about $4.85 million.
